Hyogo, Japan

Tomoo Ishikawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Gunma University, Kumamoto University, Transgenic Inc.. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomoo Ishikawa: Innovator in Inflammatory Reaction Detection

Introduction

Tomoo Ishikawa is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biomedical research, particularly in the detection of inflammatory reactions. His innovative approach has the potential to enhance our understanding of various inflammatory diseases.

Latest Patents

Ishikawa holds a patent for an "Inflammation Reporter System." This invention provides a method for detecting inflammatory reactions using a transformant or transgenic non-human animal. The system utilizes a vector that includes a promoter for a gene encoding an inflammatory cytokine, a gene encoding a reporter protein, and a gene encoding a proteolytic signal sequence. This method allows for the detection of inflammatory reactions induced by inflammatory stimulation in the transformant or transgenic non-human animal.

Career Highlights

Throughout his career, Tomoo Ishikawa has worked with various organizations, including Transgenic Inc. and Kumamoto University. His work has focused on advancing the understanding of inflammatory processes and developing innovative solutions for their detection.

Collaborations

Ishikawa has collaborated with notable colleagues such as Kenichi Yamamura and Takao Iwawaki. These partnerships have contributed to the advancement of research in the field of inflammation.

Conclusion

Tomoo Ishikawa's contributions to the detection of inflammatory reactions through his innovative patent highlight his role as a significant inventor in the biomedical field. His work continues to pave the way for advancements in understanding and treating inflammatory diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…